The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial

T Todberg; C Zachariae; A Bregnhøj; L Hedelund; K K Bonefeld; K Nielsen; L Skov; Lars  Iversen

doi:10.1111/jdv.14536

The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial

T Todberg, C Zachariae, A Bregnhøj, L Hedelund, K K Bonefeld, K Nielsen, L Skov, Lars Iversen

Institut for Klinisk Medicin - Hud- og Kønssygdomme

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Abstract

A few case stories have described patients with psoriasis who suffered from nerve injury which resulted in clearance of psoriasis (1, 2). Recently three reports have addressed a positive effect of botulinum neurotoxin A (BoNT-A) injections in patients with psoriasis (3-5). BoNT-A inhibits neuropeptide releasement and inflammatory cytokines(6), thus the hypothesis was that blocking neuromodulator could lower neurogenic inflammation resulting in improvement of psoriasis. This article is protected by copyright. All rights reserved.

Originalsprog	Engelsk
Artikelnummer	doi: 10.1111/jdv.14536
Bogserie	Journal of the European Academy of Dermatology and Venereology. Supplement
Vol/bind	32
Nummer	2
Sider (fra-til)	e81-e82
ISSN	0929-0168
DOI	https://doi.org/10.1111/jdv.14536
Status	Udgivet - aug. 2017

Adgang til dokumentet

10.1111/jdv.14536

Andre filer og links

Link to publication in Scopus

Citationsformater

Todberg, T., Zachariae, C., Bregnhøj, A., Hedelund, L., Bonefeld, K. K., Nielsen, K., Skov, L., & Iversen, L. (2017). The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial. Journal of the European Academy of Dermatology and Venereology. Supplement, 32(2), e81-e82. Artikel doi: 10.1111/jdv.14536. https://doi.org/10.1111/jdv.14536

@article{72c4257413e4462a998ff0934030b1e7,

title = "The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial",

abstract = "A few case stories have described patients with psoriasis who suffered from nerve injury which resulted in clearance of psoriasis (1, 2). Recently three reports have addressed a positive effect of botulinum neurotoxin A (BoNT-A) injections in patients with psoriasis (3-5). BoNT-A inhibits neuropeptide releasement and inflammatory cytokines(6), thus the hypothesis was that blocking neuromodulator could lower neurogenic inflammation resulting in improvement of psoriasis. This article is protected by copyright. All rights reserved.",

keywords = "Journal Article",

author = "T Todberg and C Zachariae and A Bregnh{\o}j and L Hedelund and Bonefeld, {K K} and K Nielsen and L Skov and Lars Iversen",

year = "2017",

month = aug,

doi = "10.1111/jdv.14536",

language = "English",

volume = "32",

pages = "e81--e82",

journal = "Journal of the European Academy of Dermatology and Venereology. Supplement",

issn = "0929-0168",

publisher = "Wiley-Blackwell Publishing Ltd.",

number = "2",

}

The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial. / Todberg, T; Zachariae, C; Bregnhøj, A et al.
I: Journal of the European Academy of Dermatology and Venereology. Supplement, Bind 32, Nr. 2, doi: 10.1111/jdv.14536, 08.2017, s. e81-e82.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial

AU - Todberg, T

AU - Zachariae, C

AU - Bregnhøj, A

AU - Hedelund, L

AU - Bonefeld, K K

AU - Nielsen, K

AU - Skov, L

AU - Iversen, Lars

PY - 2017/8

Y1 - 2017/8

N2 - A few case stories have described patients with psoriasis who suffered from nerve injury which resulted in clearance of psoriasis (1, 2). Recently three reports have addressed a positive effect of botulinum neurotoxin A (BoNT-A) injections in patients with psoriasis (3-5). BoNT-A inhibits neuropeptide releasement and inflammatory cytokines(6), thus the hypothesis was that blocking neuromodulator could lower neurogenic inflammation resulting in improvement of psoriasis. This article is protected by copyright. All rights reserved.

AB - A few case stories have described patients with psoriasis who suffered from nerve injury which resulted in clearance of psoriasis (1, 2). Recently three reports have addressed a positive effect of botulinum neurotoxin A (BoNT-A) injections in patients with psoriasis (3-5). BoNT-A inhibits neuropeptide releasement and inflammatory cytokines(6), thus the hypothesis was that blocking neuromodulator could lower neurogenic inflammation resulting in improvement of psoriasis. This article is protected by copyright. All rights reserved.

KW - Journal Article

UR - http://www.scopus.com/inward/record.url?scp=85030629791&partnerID=8YFLogxK

U2 - 10.1111/jdv.14536

DO - 10.1111/jdv.14536

M3 - Journal article

C2 - 28833574

SN - 0929-0168

VL - 32

SP - e81-e82

JO - Journal of the European Academy of Dermatology and Venereology. Supplement

JF - Journal of the European Academy of Dermatology and Venereology. Supplement

IS - 2

M1 - doi: 10.1111/jdv.14536

ER -

The effect of botulinum neurotoxin A in patients with plaque psoriasis - an exploratory trial

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater